- List
- By Topic
- On Map
- Search Details

Adenosine triphosphate
Need help? See RSS Feeds
Choose a feed type:

Adenosine triphosphate (27 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03685721 | Recruiting | Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease |
|
Observational |
|
NIH |
|
|
750 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03685721 | 180146 18-H-0146 |
October 11, 2018 | July 25, 2019 | May 1, 2025 | September 26, 2018 | February 11, 2019 |
|
|||||
2 | NCT02580253 | Not yet recruiting | Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
300 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT02580253 | ZYYYMedOncoLT02 | November 1, 2017 | November 2018 | December 2018 | October 20, 2015 | July 2, 2017 |
|
|||
3 | NCT00014248 | Completed | Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
All | 18 Years and older (Adult, Older Adult) | NCT00014248 | CDR0000068522 DMS-0005 ATP-DMS-0005 NCI-G01-1923 |
October 2000 | November 2002 | July 30, 2003 | March 18, 2013 |
|
||||||
4 | NCT01987999 | Completed | Eradication of Prostate Cancer Using an Adenosine-5'-Triphosphate (ATP) Inhibitor |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
60 | Male | 40 Years to 75 Years (Adult, Older Adult) | NCT01987999 | F-9892131 | February 2013 | December 2015 | December 2015 | November 20, 2013 | March 30, 2016 | ||||
5 | NCT03638063 | Recruiting | ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis |
|
|
Observational |
|
Other |
|
|
200 | All | 18 Years to 60 Years (Adult) | NCT03638063 | GuangzhouIRD01 | October 29, 2018 | January 2020 | January 2020 | August 20, 2018 | February 15, 2019 |
|
||||
6 | NCT01477983 | Completed | Kansai Plus Atrial Fibrillation Trial |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
2113 | All | 21 Years to 79 Years (Adult, Older Adult) | NCT01477983 | KPAFKUHP | KPAF | November 2011 | July 2017 | July 2017 | November 23, 2011 | August 18, 2017 |
|
||
7 | NCT01141504 | Completed | Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance |
|
|
Interventional |
Phase 1 |
|
Industry / Other |
|
|
16 | All | 20 Years to 30 Years (Adult) | NCT01141504 | MTI2010-CS01 | June 2010 | October 2011 | October 2011 | June 10, 2010 | January 10, 2012 |
|
|||
8 | NCT01499069 | Unknown † | Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
197 | All | 18 Years and older (Adult, Older Adult) | NCT01499069 | 2009-09-036 | February 2010 | December 2015 | December 2015 | December 26, 2011 | February 16, 2015 |
|
|||
9 | NCT03119818 | Completed | Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
11 | All | 18 Years to 80 Years (Adult, Older Adult) | NCT03119818 | 69HCL17_0047 | CIPHEMO | June 14, 2017 | July 29, 2017 | July 29, 2017 | April 19, 2017 | February 26, 2018 |
|
||
10 | NCT03138681 | Recruiting | Rapid Antidepressant Effects of ATP and Phosphocreatine |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
42 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT03138681 | 2017-SJNK-001 | May 3, 2017 | April 30, 2019 | April 30, 2019 | May 3, 2017 | May 8, 2017 |
|
|||
11 | NCT03169413 | Not yet recruiting | Gene Study for Infantile Onset Diabetes |
|
|
Observational |
|
Other |
|
|
100 | All | 1 Year to 3 Years (Child) | NCT03169413 | IDM | January 2018 | January 2020 | August 2020 | May 30, 2017 | May 31, 2017 | |||||
12 | NCT02255006 | Unknown † | Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
36 | All | 25 Years to 40 Years (Adult) | NCT02255006 | HI13C0580-2 | AURORAS | May 2014 | October 2014 | December 2014 | October 2, 2014 | October 2, 2014 |
|
||
13 | NCT02279511 | Completed | ATP in Alzheimer Disease |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 55 Years to 85 Years (Adult, Older Adult) | NCT02279511 | ECA4A | December 2014 | February 2016 | February 2016 | October 31, 2014 | March 29, 2017 |
|
|||
14 | NCT01130428 | Completed | Mechanical Bone Stimulation and Adenosine 5'-Triphosphate (ATP) Release in Humans |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 35 Years (Adult) | NCT01130428 | MEC 10-3-026 ATPBone-WP7.2 |
October 2010 | December 2010 | December 2010 | May 26, 2010 | April 20, 2011 |
|
|||
15 | NCT00565188 | Completed | Application of ATP Infusions in Palliative Home Care |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT00565188 | MEC 01-092.3 ZonMW 1135.0010 |
March 2002 | October 2006 | November 29, 2007 | October 25, 2016 |
|
||||
16 | NCT02286778 | Completed | Eradication of Malignant Carcinoma in the Breast Tissue |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
60 | Female | 35 Years to 75 Years (Adult, Older Adult) | NCT02286778 | F-9892131B | February 2016 | January 2017 | August 1, 2017 | November 10, 2014 | August 3, 2017 | ||||
17 | NCT00159315 | Withdrawn | ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
0 | All | 21 Years to 85 Years (Adult, Older Adult) | NCT00159315 | DHTABPT0336 | October 2002 | September 12, 2005 | June 4, 2015 |
|
|||||
18 | NCT03738943 | Not yet recruiting | Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
30 | All | 18 Years to 30 Years (Adult) | NCT03738943 | 17-7430H | February 28, 2019 | June 1, 2021 | June 1, 2021 | November 12, 2018 | January 31, 2019 | ||||
19 | NCT02721537 | Recruiting | Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
48 | All | 18 Years and older (Adult, Older Adult) | NCT02721537 | 15-006870 | TRMC-004 | September 2016 | December 2019 | June 2020 | March 29, 2016 | January 31, 2019 |
|
||
20 | NCT01508338 | Completed | The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes |
|
|
Interventional |
Not Applicable |
|
Industry / Other |
|
|
44 | Male | 18 Years to 30 Years (Adult) | NCT01508338 | MTI2012-CS01 | January 2012 | October 2012 | October 2012 | January 11, 2012 | August 1, 2017 |
|
|||
21 | NCT01827527 | Recruiting | Magnetic Resonance & Optical Spectroscopy Validation |
|
Observational |
|
Other |
|
|
150 | All | 18 Years to 89 Years (Adult, Older Adult) | NCT01827527 | TRIMDFH 422234 | March 2013 | March 2023 | March 2023 | April 9, 2013 | February 15, 2019 |
|
|||||
22 | NCT03225105 | Recruiting | M3541 in Combination With Radiotherapy in Subjects With Solid Tumors |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
24 | All | 18 Years and older (Adult, Older Adult) | NCT03225105 | MS200770_0001 | October 23, 2017 | July 3, 2019 | December 31, 2019 | July 21, 2017 | October 2, 2018 |
|
|||
23 | NCT00181155 | Completed Has Results |
Intravenous Allopurinol in Heart Failure |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
18 | All | 18 Years and older (Adult, Older Adult) | NCT00181155 | IRB: 04-10-12-06 5R01HL061912-14 |
November 2004 | December 2010 | December 2010 | September 16, 2005 | May 30, 2017 | February 9, 2016 |
|
||
24 | NCT01012284 | Completed | A Study of TMC207 in Patients With Moderately Impaired Hepatic Function |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
16 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01012284 | CR007501 TMC207-TiDP13-C112 2009-016437-99 |
January 2010 | January 2011 | January 2011 | November 13, 2009 | December 20, 2012 | ||||
25 | NCT02948335 | Completed | Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital |
|
Observational |
|
Other |
|
|
22 | All | Child, Adult, Older Adult | NCT02948335 | NVIROM | February 23, 2017 | February 19, 2018 | February 19, 2018 | October 28, 2016 | August 20, 2018 |
|
|||||
26 | NCT02659397 | Completed | A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
68 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02659397 | 1002-035 | December 2015 | July 2016 | July 2016 | January 20, 2016 | December 21, 2016 |
|
|||
27 | NCT01782027 | Suspended | Mendelian Reverse Cholesterol Transport Study |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 75 Years (Adult, Older Adult) | NCT01782027 | 815075 | October 2012 | January 2019 | January 2019 | February 1, 2013 | August 2, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.